Sign up to save your podcasts
Or
Share ESF Podcast - 22nd May. Apixaban vs rivaroxaban, SGLT2 inhibitors, ACEI and ARBs & flu risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ESF Podcast - 22nd May. Apixaban vs rivaroxaban, SGLT2 inhibitors, ACEI and ARBs & flu risk
Apixaban vs rivaroxaban in non-valvular AF, SGLT2 inhibitors and renal dysfunction risk, ACEI and ARBs use and risk of influenza, update on Medadvisor signups, and a free course from the ASHP.
View all episodes
By Dale RApixaban vs rivaroxaban in non-valvular AF, SGLT2 inhibitors and renal dysfunction risk, ACEI and ARBs use and risk of influenza, update on Medadvisor signups, and a free course from the ASHP.